Volume 6, Issue 3 (6-2021)
J Res Dent Maxillofac Sci 2021, 6(3): 19-24 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
lesan S, Khatibi M, Firoozan S. Salivary levels of uric acid, lactate dehydrogenase, and amylase in smokers versus non-smokers. J Res Dent Maxillofac Sci 2021; 6 (3) :19-24
URL: http://jrdms.dentaliau.ac.ir/article-1-320-en.html
URL: http://jrdms.dentaliau.ac.ir/article-1-320-en.html
1- Oral Medicine Dept, Faculty of Dentistry,Tehran Medical Sciences
2- Oral Medicine Dept, Faculty of Dentistry,Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. ,mandanakhatibi@yahoo.com
3- Private Practice
2- Oral Medicine Dept, Faculty of Dentistry,Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. ,
3- Private Practice
Abstract: (2084 Views)
Background and Objectives: Smoking is a hazardous habit with numerous adverse effects on oral health. It plays an important role in development of cancerous and precancerous lesions and periodontal disease. Saliva has an antioxidant system and several enzymes. This study aimed to assess the salivary levels of uric acid (UA), lactate dehydrogenase (LDH), and amylase in smokers versus non-smokers.
Materials and Methods: This descriptive, cross-sectional study was conducted on 60 individuals (30 smokers and 30 non-smokers) at the Dental School of Islamic Azad University. The participants were requested to refrain from smoking, eating and drinking prior to saliva sampling. A minimum of 1 cc of unstimulated saliva was collected from each participant by the spitting method. The level of salivary LDH was measured by the DGKC method, the level of UA was measured by the uricase assay, and the level of amylase was quantified by the kinetic photometric method. Data were analyzed by t-test, Chi-square test, Fisher’s exact test, and Mann-Whitney test (P<0.05).
Results: The salivary level of UA was 1.35±1.2 mg/dL and 1.08±1.05 mg/dL in smokers and nonsmokers, respectively with no significant difference (P=0.08). The salivary levels of amylase and LDH were 44509±38062 U/L and 420±244 IU/L in smokers and 47299±29659 U/L and 538±350 IU/L in non-smokers, respectively, with no significant difference (P>0.05).
Conclusion: Despite the slightly higher level of salivary UA in smokers, the difference between smokers and non-smokers was not significant in any of the tested parameters.
Materials and Methods: This descriptive, cross-sectional study was conducted on 60 individuals (30 smokers and 30 non-smokers) at the Dental School of Islamic Azad University. The participants were requested to refrain from smoking, eating and drinking prior to saliva sampling. A minimum of 1 cc of unstimulated saliva was collected from each participant by the spitting method. The level of salivary LDH was measured by the DGKC method, the level of UA was measured by the uricase assay, and the level of amylase was quantified by the kinetic photometric method. Data were analyzed by t-test, Chi-square test, Fisher’s exact test, and Mann-Whitney test (P<0.05).
Results: The salivary level of UA was 1.35±1.2 mg/dL and 1.08±1.05 mg/dL in smokers and nonsmokers, respectively with no significant difference (P=0.08). The salivary levels of amylase and LDH were 44509±38062 U/L and 420±244 IU/L in smokers and 47299±29659 U/L and 538±350 IU/L in non-smokers, respectively, with no significant difference (P>0.05).
Conclusion: Despite the slightly higher level of salivary UA in smokers, the difference between smokers and non-smokers was not significant in any of the tested parameters.
Type of Study: Original article |
Subject:
Oral medicine
References
1. kanehira T, Shibata K, kashiwazaki H, lnoue N, Morita M. comparison of antioxidant enzymes in saliva of elderly smokers & non-smokers. J Gerodontology 2006;23(1)::: 38-42 . [DOI:10.1111/j.1741-2358.2006.00077.x]
2. Baharvand M, GhaemMaghami A, Azimi S, Bastani H, Ahmadieh A Taghibakhsh M. comparison of superoxide Dismutase Activity in saliva of smokers and Non smokers. Southern Medical 2010; 103(5):425-427 . [DOI:10.1097/SMJ.0b013e3181d7e0d8]
3. Duskova M, Simunkava K, Hill M , Hiroskovicova H, Hoskovcova P, Kralikova E, starka L. Higher levels of salivary α-Amylase predict failure of cessation efforts in male smokers. physiol Res 2010;59 (5) :765-771 . [DOI:10.33549/physiolres.931889]
4. Shankar H, Selvam TTP. A comparative study of antioxidants in smokers and nonsmokers. APJR 2016; 1(36):152-157
5. Diaz LB,Tonzar TT, Santos DR, Souza RO, Ribas TB, Silva LF, et al. Salivary biomarkers of cellular damage and oxidative stress following of lower third molar surgical removal. Arch Health Invest 2020; 9(1):11-17 [DOI:10.21270/archi.v9i1.4865]
6. Budaneli N, kardesler L, lsik H, Willis CS, Hawkins SI, Kinane DF, Scott DA. Effects of smoking and gingival inflammation on salivary antioxidant capacity. J clin periodontal 2006;33(3):150-164 . [DOI:10.1111/j.1600-051X.2006.00892.x]
7. Didilescu AC, Hanganu SC, Galie N, Greabu M, Totan A, Stratul SI, et al. The role of smoking in changing essential parameters in body homeostasis. Pneumologia 2009;58(2):89-94.
8. Zappacosta B, Persichilli S, De Sole P ,Mordente A, Giardina B. Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers .Arch oral Biol 1999;44(6):485-8. [DOI:10.1016/S0003-9969(99)00025-4]
9. Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick AZ. Effect of cigarette smoke on salivary proteins and enzyme activities. Arch Biochem Biophys 2000; 379(2): 229-36 [DOI:10.1006/abbi.2000.1877]
10. Nagler R, Lischinsky S, Diamond E, Klein I, Reznich AZ. New insights into salivary lactate dehydrogenase of human subjects. J lab clin med 2001; 137(5): 363-9 [DOI:10.1067/mlc.2001.114710]
11. Reznich AZ, Klein I, Eiserich JP, Cross CE, Nagler RM. Inhibition of oral peroxidase activity by cigarettesmoke invivo and invitro studies. Free radic boil Med 2003;34(3) : 377-84 [DOI:10.1016/S0891-5849(02)01297-2]
12. Bakhtiari S, Baharvand M, Anbari F, Azimi S, Taheri JB. Effect of vitamin C on salivary superoxide dismutase activity in smokers. Afr.J.Biotechnol 2011; 10(37): 7267-7270
13. Abdolsamadi HR, Goodarzi MT, Mortazavi H, Robati M, Ahmadi motemayel F. comparison of salivary antioxidants in healthy smoking and non smoking men. Chang Gung Med j 2011; 34(6): 607-11
14. Fatima G, Uppin RB, Kasagani S, Tapshetty R,Rao A.Comparison of salivary uric acid level among individuals without periodontitis with that of smokers and nonsmokers with periodontitis. Journal of advanced oral research 2016; 7(1): 24-28 [DOI:10.1177/2229411220160105]
15. Javaraiah RK, David CM,. Namitha J, Tiwari R, Benakanal P. Evaluation of Salivary Lactate Dehydrogenase as a Prognostic Biomarker in Tobacco Users with and without Potentially Malignant Disorders of the Oral Cavity. South Asian J Cancer. 2020; 9(2): 93-98 [DOI:10.1055/s-0040-1721174]
16. Singh U, SolankiV, Mehrotra S, Sharma R. An Evaluation of Applicability of Salivary Uric Acid Measurement in Preeclampsia and Normal Pregnancy and Its Correlation with Serum Uric Acid. J Obstet Gynaecol India. 2019; 69(1): 62-68. [DOI:10.1007/s13224-018-1124-6]
17. Cochran B, Lunday D, Miskevich F. Kinetic Analysis of Amylase Using Quantitative Benedict's and Iodine Starch Reagents. Journal of Chemical Education 2008; 85 ( 3): 401-3 [DOI:10.1021/ed085p401]
18. Pullishery F, Panchmal GS, Siddique S. Salivary thiocyanate, uric acid and PH as biomarkers of periodontal disease in tobacco users and non users- an in vitro study. J Clin Diag Res 2015; 9(7): ZC47- ZC50 [DOI:10.7860/JCDR/2015/12783.6203]
19. Greabu M, Battino M, Totan A, Mohora M, Mitrea N, Totan C, et al. Effect of gas phase and particulate phase of cigarette smoke on salivary antioxidants, What can be role of vitamin C and pyridoxine. Pharmacol rep2007; 59(5): 613- 8
20. Hanna BE, Hamed JM, Touhala LM. Serum Uric acid in smokers. Oman med j 2008; 23(4): 269-274
21. Tahani majzoub A, Abdul E. serum uric acid level in sudaneese smokers. Sudaneese journal of public health 2013;8(4): 155-157
22. Vernerová A, Krčmová LK, Melichar B, Švec F. Non-invasive determination of uric acid in human saliva in the diagnosis of serious disorders. Clin Chem Lab Med 2020; aop [DOI:10.1515/cclm-2020-1533]
23. Nater UM, Rohlealer N, Ehlert U, Kirschbaum C. Determinants of the diurnal course of salivary α-amylase. Psychoneuroendocrinology 2007;32(4):392-401 [DOI:10.1016/j.psyneuen.2007.02.007]
24. Ahmadi-Motamayel F, Falsafi P, Goodarzi MT, Poorolajal J. Evaluation of salivary catalase, vitamin C and alpha-amylase in smokers and non-smokers: a retrospective cohort study. J Oral pathol Med 2017; 46(5): 377-380 [DOI:10.1111/jop.12495]
25. Nagler RM. Altered salivary profile in heavy smokers and its possible connection to oral cancer. J boil markers 2007;22(4):274-280 [DOI:10.1177/172460080702200406]
26. Nagler RM, Klein I, Reznich AZ. The interaction between saliva and cigarette smoke and its devastating biological effects as related to oral cancer. Harefuah 2001;140(7);614-8.
27. Weiner D, Levy Y, Khankin EV, Reznikh AZ. Inhibition of salivary amylase activity by cigarette smoke aldehydes. Physiol pharmacol 2008; 59(6): 727-37
28. Avezov K, Reznich AZ, Aizenbud D. LDH enzyme activity in human saliva: the effect of exposure to cigarette smoke and its different components. Arch oral biol 2014; 59(2): 142-8 [DOI:10.1016/j.archoralbio.2013.11.003]
29. Zappacosta B, Persichillis S, Mordente A, Minucci A, Lazzaro D, Meucci E, et al. Inhibition of salivary enzymes by cigarette smoke and the protective role of glutathione. Hum Exp Toxicol 2002; 21(1):7-11 [DOI:10.1191/0960327102ht202oa]
30. Nagler R, Lischinsky S, Diamond E, Drigues N, Klein I, Reznick AZ. Effect of cigarette smoke on salivary protein and enzyme activities . Arch Biochem Biophys 2000; 379(2): 229-236 [DOI:10.1006/abbi.2000.1877]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
